Motesanib Terminated Phase 2 Trials for Solid Tumors Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00360867An Open Label Treatment Extension Study of AMG 706